Home - Professor Marie-Claude Boily


  • Background and objective: People who inject drugs (PWID) account for over half of new HIV infections in Eastern Europe and central Asia, where opioids continue to be the dominant illicit drugs injected. Stimulants including amphetamines (ATS) have been associated with HIV infection risk in several settings. We sought to examine whether primary ATS injection was associated with greater HIV risk, compared to opioid injection in two European locales with significant HIV epidemics. Methods: PWID in Kohtla-Järve and St. Petersburg were recruited using respondent-driven sampling in 2012-2013. Survey data on demographic characteristics, service use, injecting and sexual risk behaviours and HIV-status (and HCV in Kohtla-Järve) were compared between primary opioid and ATS injectors using logistic regression models. Results: Of 591 injectors recruited in Kohtla-Järve and 811 in St. Petersburg, 195 (33%) and 27 (4%) primarily injected ATS in each city. In both cities, ATS injectors were younger than opioid injectors, initiated injection later, injected less frequently and were more likely to have been paid for sex. In both cities, PWID had high levels of multiple sex partners. In Kohtla-Järve, ATS-injectors had lower odds of back-loading and greater odds of polydrug use than opioid-injectors. In St. Petersburg, where over half of PWID reported unsafe sharing practices, ATS-injectors were less likely to report these practices. ATS-injection was negatively associated with being HIV positive in Kohtla-Järve (aOR = 0.6; 95%CI: 0.5-0.8) and St. Petersburg (aOR = 0.3; 95%CI: 0.1-0.7). ATS-injection was negatively associated with HCV-reactivity in Kohtla-Järve (aOR = 0.5; 95%CI: 0.3-0.6). Conclusions: In both locations, primary ATS injection was associated with lower injecting risk behaviours, lower odds of HIV and being paid for sex compared to opioid injection. Interventions targeting the characteristics and needs of ATS injectors are needed to increase contact with services and reduce sexual and injecting risk. Harm reduction services, including sexual risk reduction, need to be expanded for all PWID in St. Petersburg.

    Источник: https://www.researchgate.net/profile/Marie-Claude_Boily


    Опубликовано: 14.02.2018 | Автор: Бажен

    Рейтинг статьи: 5


    Всего 9 комментариев.

    15.03.2018 weiprinegsa:
    Montréal au temps de la variole, Marie-Claude Boily nous revient avec ses personnages Victor et Amélia Desmarais.

    12.02.2018 Капитон:
    Marie Claude Boily Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK Sex Transm Infect 87:646-53.

    20.02.2018 stimineth:
    Nature, 352:581-587. Boily MC, Lowndes C, Alary M. (2002). The impact of HIV epidemic phases on the effectiveness of core group interventions.

    26.02.2018 Савва:
    Read 212 publications, and contact Marie-Claude Boily on ResearchGate, the professional network for scientists.

    25.02.2018 Анфиса:
    Get authenticated information for Marie Claude Boily. Find local businesses nearby Marie Claude Boily.